Risk of thromboembolic phenomena in patients with inflammatory bowel disease

被引:8
作者
Suarez Ferrer, Cristina [1 ]
Vera Mendoza, Maria Isabel [1 ]
Amo San Roman, Leticia [1 ]
Gonzalez Lama, Yago [1 ]
Calvo Moya, Marta [1 ]
Garcia Casas, Mercedes [1 ]
Abreu Garcia, Luis [1 ]
机构
[1] Hosp Univ Puerta de Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2012年 / 35卷 / 09期
关键词
Thromboembolic phenomena; Inflammatory bowel disease; Risk of thrombosis; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM;
D O I
10.1016/j.gastrohep.2012.07.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors associated with developing TEP in patients with IBD in our center. Material and methods: Data were retrospectively collected from January 1995 to December 2011 from 23 patients. A total of 61% were diagnosed with Crohn's disease (CD) and 39% with ulcerative colitis (UC) according to routine criteria. Results: When the Montreal classification was used, 58% of the patients with CD had an inflammatory pattern (B1), 25% a stenosing pattern (B2) and 17% a fistulizing pattern (B3). Half the patients had ileocolic involvement (L3), one-third had colonic involvement (L2) and the remainder had Heal involvement (L1). Among patients with UC according to the Montreal classification, 78% had extensive colitis (E3), 11% had left colonic involvement (E2) and 11% had proctocolitis (El). During the event, almost half the patients with UC had severe inflammatory activity (S3; 44%), 33% had mild-moderate activity (51: 22%, S2: 11%) and only 22% were in remission (SO). Overall, at the time of the TEP, 48% of the patients had mild-moderate activity and 22% had severe activity. Likewise, 44% were hospitalized at the time of the event. In UC, an increase in the prevalence of TEP was found in admitted patients (66%). None of the patients had a family history of TER two patients (9%) had associated thrombophilia and 26% were active smokers. There were no TEP during pregnancy. Only one patient was taking contraceptive pills when the event occurred. The most frequent forms of TEP were deep vein thrombosis of the legs (55%) followed by pulmonary thromboembolism (25%). Conclusions: TEP are relatively frequent in patients with IBD, with a strong impact on morbidity and mortality. In our series, risk factors for these events were more extensive involvement (any of the groups) and severe inflammatory activity. No significant association between classical risk factors such as the use of contraceptives, pregnancy, coagulation disorders or smoking and the risk of TEP were found. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 50 条
[31]   Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease [J].
Mironova, Olga Iu ;
Isaikina, Mariia A. ;
Khasieva, Sofiia A. .
TERAPEVTICHESKII ARKHIV, 2021, 93 (12) :1533-1538
[32]   Risk factors for osteoporosis in inflammatory bowel disease patients [J].
Carla Andrade Lima ;
Andre Castro Lyra ;
Raquel Rocha ;
Genoile Oliveira Santana .
World Journal of Gastrointestinal Pathophysiology, 2015, 6 (04) :210-218
[33]   Thrombophilic Risk Factors in Patients With Inflammatory Bowel Disease [J].
Yazici, Ayten ;
Senturk, Omer ;
Aygun, Cem ;
Celebi, Altay ;
Caglayan, Cigdem ;
Hulagu, Sadettin .
GASTROENTEROLOGY RESEARCH, 2010, 3 (03) :112-119
[34]   Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease [J].
Koutroumpakis, Efstratios I. ;
Tsiolakidou, Georgia ;
Koutroubakis, Ioannis E. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (05) :461-468
[35]   Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events [J].
Papa, A ;
Danese, S ;
Piccirillo, N ;
Toriani-Terenzil, C ;
Bartolozzi, F ;
Piscaglia, AC ;
Grillo, A ;
Leone, G ;
Gentiloni-Silveri, N ;
Gasbarrini, G ;
Gasbarrini, A .
HEPATO-GASTROENTEROLOGY, 2003, 50 (49) :132-135
[36]   The risk of cardiovascular complications in inflammatory bowel disease [J].
Czubkowski, Piotr ;
Osiecki, Marcin ;
Szymanska, Edyta ;
Kierkus, Jaroslaw .
CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (04) :481-491
[37]   Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease [J].
Yuhara, H. ;
Steinmaus, C. ;
Corley, D. ;
Koike, J. ;
Igarashi, M. ;
Suzuki, T. ;
Mine, T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (10) :953-962
[38]   Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease? [J].
Gandhi, Sumeet ;
Narula, Neeraj ;
Marshall, John K. ;
Farkouh, Michael .
AMERICAN JOURNAL OF MEDICINE, 2012, 125 (10) :956-962
[39]   Elevated risk of venous thromboembolic events in patients with inflammatory myopathies [J].
Nowak, Michal ;
Krolak-Nowak, Katarzyna ;
Sobolewska-Wlodarczyk, Aleksandra ;
Fichna, Jakub ;
Wlodarczyk, Marcin .
VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 :233-238
[40]   Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors [J].
Ohta, Yuki ;
Arai, Makoto ;
Nakagawa, Tomoo ;
Akizue, Naoki ;
Ishikawa, Kentaro ;
Hamanaka, Shinsaku ;
Koseki, Hirotaka ;
Taida, Takashi ;
Okimoto, Kenichiro ;
Saito, Keiko ;
Yoshihama, Sayuri ;
Maruoka, Daisuke ;
Matsumura, Tomoaki ;
Katsuno, Tatsuro ;
Kato, Naoya .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (05) :870-879